[1] Youil R, Su Q, Toner TJ, et al.Comparative study of influenza virus replication in Vero and MDCK cell lines[J]. Journal of Virological Methods, 2004, 120(1):23-31. [2] Audsley JM, Tannock GA.Cell-based influenza vaccines:Progress to date[J]. Drugs, 2008, 68(11):1483-1491. [3] Mabrouk T, Ellis RW.Influenza vaccine technologies and the use of the cell-culture process(cell-culture influenza vaccine)[J]. Dev in Biol, 2002, 110(1):125-134. [4] Keen MJ, Rapson NT.Development of a serum-free culture medium for the large scale production of recombinant protein from a Chinese hamster ovary cell line[J]. Cytotechnol, 1995, 17(3):153-163. [5] Rourou S, van der Ark A, van der Velden T, et al. Development of an animal-component free medium for vero cells culture[J]. Biotechnology Progress, 2010, 25(6):1752-1761. [6] Merten OW.Development of serum-free media for cell growth and production of viruses/viral vaccines--safety issues of animal products used in serum-free media[J]. Dev in Biol, 2002, 111:233-257. [7] Tapia F, et al.Production of high-titer human influenza A virus with adherent and suspension MDCK cells cultured in a single-use hollow fiber bioreactor[J]. Vaccine, 2014, 32(8):1003-1011. [8] Ru AL, Jacob D, Transfiguracion J, et al.Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing[J]. Vaccine, 2010, 28(21):3661-3671. [9] Lorizate M, Kräusslich HG.Role of lipids in virus replic-ation[J]. Cold Spring Harb Perspec Biol, 2011, 3(10):1-20. [10] Lohr V, Rath A, Genzel Y, et al.New avian suspension cell lines provide production of influenza virus and MVA in serum-free media:Studies on growth, metabolism and virus propagation[J]. Vaccine, 2009, 27(36):4975-4982. [11] Kalbfuss B, Knöchlein A, Kröber T, et al.Monitoring influenza virus content in vaccine production:Precise assays for the quantitation of hemagglutination and neuraminidase activity[J]. Biologicals, 2008, 36(3):145-161. [12] Bock A, Schulze-Horsel J, Schwarzer J, et al.High-density microcarrier cell cultures for influenza virus production[J]. Biotechnology Progress, 2011, 27(1):241-250. [13] Wang H, Guo S, Li Z, et al.Suspension culture process for H9N2 avian influenza virus(strain Re-2)[J]. Archives of Virology, 2017, 162(10):3051-3059. [14] 李春艳, 肖晶, 李曦, 等. 微载体规模比培养MDCK细胞增殖H9N2亚型禽流感病毒的研究[J]. 中国人兽共患病学报, 2009(12):1149-1153. [15] Fontaine KA, et al.Dengue virus induces and requires glycolysis for optimal replication[J]. J Virol, 2015, 89(4):2358-2366. [16] Ritter JB, Wahl AS, Freund S, et al.Metabolic effects of influenza virus infection in cultured animal cells:Intra- and extracellular metabolite profiling[J]. BMC Syst Biol, 2010, 4(1):61-83. [17] Huang D, Xia-Hou K, Liu XP, et al.Rational design of medium supplementation strategy for improved influenza viruses production based on analyzing nutritional requirements of MDCK Cells[J]. Vaccine, 2014, 32(52):7091-7097. [18] Genzel Y, Behrendt I, et al.Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture[J]. Vaccine, 2004, 22(17-18):2202-2208. [19] Saito K, Nishijima M, Kuge O.Phosphatidylserine is involved in gene expression from Sindbis virus subgenomic promoter[J]. Biochem Biophys Res Commun, 2006, 345(2):878-885. [20] Kaushik R, Ratner L.Role of human immunodeficiency virus type 1 matrix phosphorylation in an early postentry step of virus replication[J]. Journal of Virology, 2004, 78(5):2319-2326. [21] Lohr V, Genzel Y, Behrendt I, et al.A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor[J]. Vaccine, 2010, 28(38):6256-6264. [22] Chen P, Harcum SW.Effects of amino acid additions on ammon-ium stressed CHO cells[J]. J Biotechnol, 2005, 3:277-286. |